— Know what they know.
Not Investment Advice

HNSBF OTC

Hansa Biopharma AB
1W: -11.1% 1M: -11.1% 3M: +13.4% YTD: +13.1% 1Y: +9.7%
$3.29
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 44 · $328.0M mcap · 64M float · 0.0005% daily turnover · Short 100% of daily vol

📊 Key Metrics

TTM
$189M
Revenue
-3.7% YoY
$-768M
Net Income
-28.9% YoY
$-545M
Free Cash Flow
+12.1% YoY
53.6%
Gross Margin
-361.9%
Op. Margin
-541.7%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE159.8%
ROA-80.5%
ROIC1182.7%

Valuation

P/E-4.2
P/B-6.5
EV/EBITDA0.0

Leverage

Debt/Equity-1.99
Current Ratio1.25
Interest Cov.-3.1x

Quality Scores

Piotroski F2/9
Altman Z—
Beneish M-3.74

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms